The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new biotechnology methods instead to spur innovation in the pharmaceutical ...
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from ...
Asia's best solutions partner, will participate in NVIDIA GTC for the third consecutive year under the theme "From AI to ...
The Atlas will expand known evolutionary genetic diversity by 100x, collecting novel genomic data from over 100 million new species across thousands of ...
Quantinuum, Nelipak, and Global Innovation Labs' newly opened hubs in Singapore are aimed at advancing research, product ...
A persistent tension exists between the drive for rapid technological advancement, the mandate for government oversight, and the paramount importance of patient safety. This dynamic which scrutinized ...
Drug developers will be able to use alternatives to animal testing and possibly get new products to market faster under draft guidance issued Wednesday by the FDA. In a press release, officials said ...
From navigation systems to hardware, here are nine spine technologies earning FDA certifications and clearances since Jan. 19 ...
Image courtesy of Revolve Surgical] Revolve Surgical announced today that it received FDA 510(k) clearance for its surgical ...
LOS ANGELES, CA, UNITED STATES, March 18, 2026 /EINPresswire.com/ -- From January 20 to 27, 2026, the 40th AAAI ...
CytoNiche’s 3D FloTrix™ platform won the Emerging Bioprocessing Supplier – Downstream award at ABEA 2026, recognising ...
The latest action fits with Makary’s promise to overhaul the FDA while speaking to a priority of Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine skeptic who has long theorized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results